News
Public · Published
CVS Health Turns To Profit In Q3; Revises FY26 View
CVS Health reported third-quarter net income of $2.172 billion, versus a $3.975 billion loss a year earlier, and revenue rose 5.4% to $108.399 billion. It said the profit comparison benefited from no repeat of a prior-year $5.7 billion goodwill impairment charge and revised its fiscal 2026 outlook.
Published:
Updated:
What happened
CVS Health reported third-quarter net income of $2.172 billion, versus a $3.975 billion loss a year earlier, and revenue rose 5.4% to $108.399 billion. It said the profit comparison benefited from no repeat of a prior-year $5.7 billion goodwill impairment charge and revised its fiscal 2026 outlook.
Confirmed
Global impact / market context
The higher revenue and adjusted earnings suggest improvement in operating performance, especially in Health Care Benefits, where CVS cited progress on its margin recovery plan. But the headline profit also reflects an accounting charge that did not recur, so it should not be read as entirely new operating strength.
Analyst inference
CVS raised its fiscal 2026 minimum earnings-per-share outlook to $6.98 from a previous range of $6.84 to $7.04, while the supplied article reports shares down 1.77% in pre-market trading. The outlook change and operating results provide competing signals about expected earnings and investor positioning.
Analyst inference
What to watch
- Check subsequent reports for whether Health Care Benefits continues improving adjusted operating income, since that segment’s progress was cited as a main driver of higher adjusted earnings per share. Analyst inference
- Look for the complete fiscal 2026 adjusted earnings-per-share guidance; the supplied article cuts off before giving the revised figure, limiting comparison with earlier expectations. Confirmed
- Track revenue and earnings contributions from Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness to see whether growth across these segments supports CVS’s revised outlook. Analyst inference
Evidence
- Original source link unavailable